360 High-Risk Vulnerability Immunization Tool V2.0 vs ASPIA Automated Vulnerability Management System: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

ASPIA Automated Vulnerability Management System: Automated vuln mgmt platform for discovery, prioritization & remediation. built by ASPIA Infotech Pvt. Ltd.. Core capabilities include Automated vulnerability discovery and asset consolidation, Risk-based vulnerability prioritization, Vulnerability data ingestion from external security tools..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. ASPIA Automated Vulnerability Management System differentiates with Automated vulnerability discovery and asset consolidation, Risk-based vulnerability prioritization, Vulnerability data ingestion from external security tools.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). ASPIA Automated Vulnerability Management System is developed by ASPIA Infotech Pvt. Ltd.. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and ASPIA Automated Vulnerability Management System serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.